188 related articles for article (PubMed ID: 1730880)
1. Constitutive versus cell cycle regulation of c-myb mRNA expression correlates with developmental stages in murine B lymphoid tumors.
Catron KM; Purkerson JM; Isakson PC; Bender TP
J Immunol; 1992 Feb; 148(3):934-42. PubMed ID: 1730880
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of the c-myb proto-oncogene marks the pre-B cell/B cell junction in murine B lymphoid tumors.
Bender TP; Kuehl WM
J Immunol; 1987 Dec; 139(11):3822-7. PubMed ID: 3316389
[TBL] [Abstract][Full Text] [Related]
3. Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes.
Golay J; Cusmano G; Introna M
J Immunol; 1992 Jul; 149(1):300-8. PubMed ID: 1376749
[TBL] [Abstract][Full Text] [Related]
4. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
[TBL] [Abstract][Full Text] [Related]
5. Effect of the myb gene product on expression of the PCNA gene in fibroblasts.
Travali S; Ferber A; Reiss K; Sell C; Koniecki J; Calabretta B; Baserga R
Oncogene; 1991 Jun; 6(6):887-94. PubMed ID: 1712444
[TBL] [Abstract][Full Text] [Related]
6. Growth regulated expression of B-myb in fibroblasts and hematopoietic cells.
Reiss K; Travali S; Calabretta B; Baserga R
J Cell Physiol; 1991 Sep; 148(3):338-43. PubMed ID: 1717494
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cell proliferation: late down-regulation of c-myb preceding myelo-monocytic cell differentiation.
Yen A; Samuel V; Forbes M
J Cell Physiol; 1992 Oct; 153(1):147-56. PubMed ID: 1522128
[TBL] [Abstract][Full Text] [Related]
8. Redundant functions of B-Myb and c-Myb in differentiating myeloid cells.
Golay J; Broccoli V; Borleri GM; Erba E; Faretta M; Basilico L; Ying GG; Piccinini G; Shapiro LH; Lovrić J; Nawrath M; Mölling K; Rambaldi A; Introna M
Cell Growth Differ; 1997 Dec; 8(12):1305-16. PubMed ID: 9419419
[TBL] [Abstract][Full Text] [Related]
9. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
Gudas JM; Klein RC; Oka M; Cowan KH
Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle dependent growth factor regulation of gene expression.
Morgan CJ; Pledger WJ
J Cell Physiol; 1989 Dec; 141(3):535-42. PubMed ID: 2512304
[TBL] [Abstract][Full Text] [Related]
12. Microsatellite deletions in the c-myb transcriptional attenuator region associated with over-expression in colon tumour cell lines.
Thompson MA; Flegg R; Westin EH; Ramsay RG
Oncogene; 1997 Apr; 14(14):1715-23. PubMed ID: 9135073
[TBL] [Abstract][Full Text] [Related]
13. The expression of c-fos, c-jun, and c-myc genes is regulated by heat shock in human lymphoid cells.
Bukh A; Martinez-Valdez H; Freedman SJ; Freedman MH; Cohen A
J Immunol; 1990 Jun; 144(12):4835-40. PubMed ID: 2112575
[TBL] [Abstract][Full Text] [Related]
14. The murine c-rel proto-oncogene encodes two mRNAs the expression of which is modulated by lymphoid stimuli.
Grumont RJ; Gerondakis S
Oncogene Res; 1990; 5(4):245-54. PubMed ID: 2204017
[TBL] [Abstract][Full Text] [Related]
15. The A-myb gene is preferentially expressed in tonsillar CD38+, CD39-, and sIgM- B lymphocytes and in Burkitt's lymphoma cell lines.
Golay J; Erba E; Bernasconi S; Peri G; Introna M
J Immunol; 1994 Jul; 153(2):543-53. PubMed ID: 8021494
[TBL] [Abstract][Full Text] [Related]
16. B-Myb prevents growth arrest associated with terminal differentiation of monocytic cells.
Bies J; Hoffman B; Amanullah A; Giese T; Wolff L
Oncogene; 1996 Jan; 12(2):355-63. PubMed ID: 8570212
[TBL] [Abstract][Full Text] [Related]
17. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
Gogusev J; Barbey S; Nezelof C
Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
[TBL] [Abstract][Full Text] [Related]
18. Relationship of acivicin-induced monocytoid differentiation of human myeloid leukemia cells to acivicin-induced modulation of growth factor, cytokine, and protooncogene mRNA expression.
Weinberg JB; Mason SN
Cancer Res; 1991 Feb; 51(4):1202-9. PubMed ID: 1997162
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2.
Hogg A; Schirm S; Nakagoshi H; Bartley P; Ishii S; Bishop JM; Gonda TJ
Oncogene; 1997 Dec; 15(24):2885-98. PubMed ID: 9416832
[TBL] [Abstract][Full Text] [Related]
20. Oncogene expression in autoimmune mice.
Mountz JD; Mushinski JF; Mark GE; Steinberg AD
J Mol Cell Immunol; 1985; 2(3):121-31. PubMed ID: 3916923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
